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SUMMARY
The implantation rate ofcardiacpacemakers in Northem Ireland rosefrom 55-8
per million population In 1979 to over 180 per million in 1988, with the
emergence of a second pacemaker implantation centre. However, the inplant-
ation rate in Northem Ireland remains less than that of many other countries.
Overtheperiod complete heartblockfeli as an indicationfrom 45% to 34% and
sinus node disease rose from 16% to 28%. Symptoms necessitating pacing
remained unchanged, syncope being the most common. Ventricular demand
pacemakers constituted a lowerproportion ofimplants than anywhere else in the
world and more atrial demand and dual chamberpacemakers were implanted
than in most other counties. Insufficientpatients arebeingreferredforpacing in
Northem Ireland but a high proportion ofthose who are referred receive modern
sophisticated pacemakers.
INTRODUCTION
The first fully implantable cardiac pacemaker was inserted in 19591 and the first
implant in Northern Ireland was in 1969 by Dr J Geddes. Since then there have
been rapid advances in pacemaker technology, including the development of
stable atrial and ventricular leads that can be inserted intravenously, and the
development of smaller and longer lasting pacemakers with sophisticated
functions which can beimplanted underlocal anaesthetic with minimal morbidity.
Permanent pacemaker implantation has become a relatively straightforward
techniqueand theindicationsforpacingarenolonger restrictedtolife-threatening
bradycardias. This has resulted in a rapid increase in the numbers of pacemakers
implanted worldwide.
This paper documents the change in pacing practice in Northern Ireland over
the ten year period 1979-1988 and compares with other parts of the United
Kingdom and the rest of the world.
METHODS
Permanent pacemakers are implanted at two centres in Northern Ireland: the
Belfast City Hospital and the Royal Victoria Hospital. These hospitals register the
details of permanent pacemaker implantations with the British Pacing Group
database. Data for the two hospitals were obtained from the British PacingGroup
with permission from the cardiologists in each hospital. This was compared with
hospital records to exclude duplications, omissions or other inaccuracies.
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Sex, age at pacemaker implantation, electrocardiographic indications for
implantation, symptoms requiring pacing, and pacing modes employed were
recorded. These results were compared with published world data for 1986.2
RESULTS
Only first time implantations are considered. The total number of pacemakers
implanted over the ten year period in both centres was 1935, with the greater
proportion in the Royal Victoria Hospital (63%). The numbers implanted annually
increased from 87 in 1979 to 290 in 1988 (Table 1). The proportion implanted
in the Belfast City Hospital rose from 17% to 53% over this period. The initial
implantation rate per million population was 55
-8 in 1979 rising to 152 in 1986
and 185'9 in 1988 (Northern Ireland population 1 56 million- 1981 census).
Theoverall United Kingdomfigures are 111 permillion in 1979 and 148 in 1986.
The average age at implantation has gradually increased from approximately 67
in 1980 to nearly 72 in 1988, with a slight excess of males in most years.
TABLE I
Numbers offirst timepacemaker implantations in two hospitals in Northern
Ireland, and implantation rateper million population
Pacemaker numbers Implantation rate
Year RVH BCH Total (per million)
1979 72 15 87 55-8
1980 98 26 124 79 5
1981 105 31 136 86*6
1982 143 35 178 114-1
1983 124 56 180 115*4
1984 131 81 212 135-9
1985 150 85 235 150*6
1986 141 96 237 151-9
1987 122 134 256 164*1
1988 137 153 290 185*9
Total 1223 712 1935 124'0
Indications forpacing
The main indications forpacing wereheart block(includingcompleteheartblock,
second and first degree heart block, bundle branch block and atrial fibrillation
with bradycardia) and sinus node disease. The number ofpacemakers implanted
for complete heart block gradually increased over the first five year period but
remained approximately 95 per year thereafter. The relative frequency of this
diagnosis fell from 44-8% to 33
-8% of the total over the period. There was a
rise in numbers ofpacemakers implanted forsinus node diseasefrom 14 in 1979
(16 1 %) to 78 in 1988 (27 8%). No patients were paced for carotid sinus
hypersensitivity in 1979 whereas in 1988 this indication accounted for 5'3% of
thetotal. There was no change in thefrequency ofimplantation forotherformsof
heart block, with second degree heart block accounting for approximately 9%,
bundle branch block 4%, and atrial fibrillation with bradycardia 6% throughout
the period.
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Symptoms
Symptoms atthe time ofpacing have remained fairly constant. Syncope has been
the mostfrequent indication, around 50% for the whole period. Dizzyspells have
risen from 12% to 20%. These two symptoms represent definite indications for
pacing about which there is little controversy (ifthey are caused by bradycardia).
Less definite symptoms such as bradycardia alone have decreased over the ten
yearperiod from 18% to6%.Thesethree symptoms haveconsistently accounted
for more than 75% of those implanted, but their proportion has decreased as
other indications, such as pacing for tachycardia have increased.
Pacing modes
This is the area where there has been the greatest change over the ten year
period. In 1979 single chamber ventricular demand pacing was the predominant
mode of pacing and accounted for 87% of the total, the other two modes used
being atrioventricular sequential (DVI) and atrial demand (AAI).
Over the period the frequency of these three modes of pacing reduced and this
was associated with the development and use of other more sophisticated modes
of pacing - two more dual chamber modes (DDD and DDI), rate responsive
pacing (VVIR) and antitachycardia pacing (Table 11).
TABLE II
Different pacing modes used in 1979 and 1988
Pacemakers implanted (%)
Mode 1979 1988
Single chamber:
Ventricular demand (VVI) 76 (87) 120 (40)
Atrial demand (AAI) 5 (5) 22 (8)
Dual chamber:
Atrioventricular sequential (DVI) 6 (7) 25 (9)
(DDD) 0 (0) 89 (31)
(DDI) 0 (0) 11 (4)
Rate responsive (VVIR) 0 (0) 20 (7)
Others 0 (0) 3 (1)
UK and world data
In 1986 the implantation rate per million population was lowerin Northern Ireland
and in the UK as a whole, compared with most other Western countries (Figure).
Ventricular demand mode accounted for a much lower proportion of the total in
Northern Ireland, meaning that the more sophisticated atrial demand and dual
chamber pacemakers were used more frequently than in most other countries.
Symptoms resulting in pacemaker implantation differed. In Northern Ireland and
in the UK as a whole relatively small numbers were implanted forsymptoms such
as bradycardia, whereasthis indication was more common in those countrieswith
higher implantation rates.
© The Ulster Medical Society, 1990.
1334The Ulster Medical Journal
500
. Ventricular Demand
_ Others 450
400
0
350
300
250
=200
-. 150
E
100 50Lii
0-
NI UK BEL FRG FRA USA CAN ICE CZE GEC
Figure. Implantation rates, and proportion ventricular demand mode, for Northern Ireland and the
UK compared with other countries for 1986. (Bel = Belgium, FRG = West Germany, Fra = France,
Can =Canada, Ice = Iceland, Cze = Czechoslovakia, Gec= Greece).
DISCUSSION
During the ten year period many advances have occurred in pacemaker
technology, and permanent pacemaker implantation is now a straightforward
procedure performed under local anaesthesia, with a minimal morbidity and
mortality. There is now no doubt that mortality in patients with complete heart
block, whether symptomatic or not, is significantly improved with pacing and all
patients with this condition should be paced.3 Second degree heart block is
also a frequent indication. Mobitztype 11 block occurswhenthe blockis belowthe
level of the atrioventricular node and usually progresses to higher degree atrio-
ventricular block with Stokes Adams attacks and the risk of sudden death.4
Chronic type I second degree block (as opposed to the transient type that occurs
following an inferior myocardial infarction) was generally believed to have a
relatively benign course, and pacing was considered only for extreme bradycardia
or ifthe patient was symptomatic.5 Recent work would suggest thatthe prognosis
in this condition is not so good and pacing should be considered.6
Patients with bifascicular block are at higher risk of development of high-grade
atrioventricular block,7 but the best means of predicting those most at risk is not
clear. At present patients with bifascicular block and a prolonged PR interval with
a history of syncope for which no other cause can be found probably require
pacing.8 It is generally agreed that mortality in sinus node disease has not been
shown to be improved by pacing, and thatpatients with thiscondition shouldonly
be paced for relief ofsuch symptoms as syncope and heart failure.9 Carotid sinus
hypersensitivity resulting in syncope is now another frequent indication for
pacing, accounting for 5 3% of all cases in Northern Ireland in 1988. Pacing
improves symptoms in a significant proportion of these patients.10 Tachycardia
control and termination represents a small but significant proportion of pace-
makers implanted.
©i The Ulster Medical Society, 1990.
134Cardiac pacing
The implantation rate in Northern Ireland and throughout the UK is much lower
than in many countries throughout the world. The most recent figures available
are for 1986, when most western European and North American countries were
implanting more than 200 per million, and some countries more than 400 per
million population.2 The reasons forthese differencesin implantation rates are not
clear. Possible explanations are a lower prevalence of conditions requiring pace-
maker implantation in the UK, underdiagnosis or undertreatment of conditions
requiring pacing, or overimplantation in other countries.
The high rate of bradycardia as a symptom and sinus node disease as an
indication for pacing in some countries with high implantation rates may reflect
inappropriate pacing of asymptomatic patients with sinus node disease. It was
suggested in 1984 that too many pacemakers were being implanted in the USA.11
This resulted in the introduction of stricter criteria for pacemaker implantation
and was followed by a reduction in the implantation rate in that country from 518
per million in 1981 to 359 per million in 1986. This figure is still over twice that of
the UK for that year.
A reason for the lower implantation rate in the UK may be a different prevalence
of conditions requiring pacing. Shaw and Kekwick12 carried out an eight year
survey in the Devon area in which they asked general practitioners to report
patients who they thought had abnormal bradycardias. They included complete
heart block and sinus node disease as indications for pacemaker implantation and
found an incidence of complete heart block of 97 per million and symptomatic
sinus node disease of 77 per million, a total rate of 174 patients per million
requiring pacemaker implantation per year for these conditions. In Northern
Ireland in 1988 the implantation rate was 20 per million for second degree heart
block, 15 per million for atrial fibrillation and bradycardia, 10 per million for
carotid sinus hypersensitivity, 3 per million for bundle branch block and 20 per
million for other indications. Taken with the 174 per million estimated by Shaw
and Kekwick for complete heart block and sinus node disease, this would suggest
that a total implantation rate of 250-300 per million would be more appropriate.
Thus the discrepancy between the implantation rates in the UK and other
countries may be due to a degree of overtreatment in those countries, but it
also seems that there is undertreatment of patients with conditions requiring a
permanent pacemaker in the UK. Examination of data from Northern Ireland may
suggest reasons why this should be so. Prior to 1983 pacing in Northern Ireland
was performed predominantly in one centre, the Royal Victoria Hospital, where
143 implants were performed in 1982. In that year only 35 implants were
performed in the Belfast City Hospital. However, over the next five years the
number of implantations in the latter hospital increased to 153 in 1988, but there
has not been any reduction in the numbers implanted in the RVH. This would
suggest that the implantation rates reflect the number of centres performing
implantation, greater availability of a pacing service resulting in a greater referral
for pacing. It may be that the UK practice of implanting pacemakers in regional
centres specialising in pacing gives riseto lower referral rates forinvestigation and
treatment of bradycardias and syncope than if pacing were to be performed in
district general hospitals. It has been suggested that the higher implantation rate
in the USA may be due to the widespread availability of a pacing centre in almost
every community hospital.13
Fewer ventricular demand pacemakers are implanted in Northern Ireland than
in the UK or any other country, but more atrial demand and dual chamber
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pacemakers are used. The high implantation rate for these latter types of
pacemakers probably reflects the fact that in Northern Ireland pacing is carried
out in two specialised cardiology units with particular interests in pacing.
I would like to thank the cardiologists in both the Belfast City Hospital and Royal Victoria Hospital, in
particular Dr D B O'Keeffe and Dr S Webb, for their help in compiling these data. This paper was
presented to the Irish Cardiac Society in December 1989.
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